HomeCompareBRYAF vs PFE

BRYAF vs PFE: Dividend Comparison 2026

BRYAF yields 2976.19% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BRYAF wins by $421400563152.05M in total portfolio value
10 years
BRYAF
BRYAF
● Live price
2976.19%
Share price
$0.07
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$421400563152.10M
Annual income
$395,274,393,919,294,200.00
Full BRYAF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — BRYAF vs PFE

📍 BRYAF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBRYAFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BRYAF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BRYAF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BRYAF
Annual income on $10K today (after 15% tax)
$252,976.19/yr
After 10yr DRIP, annual income (after tax)
$335,983,234,831,400,060.00/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, BRYAF beats the other by $335,983,234,831,377,700.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BRYAF + PFE for your $10,000?

BRYAF: 50%PFE: 50%
100% PFE50/50100% BRYAF
Portfolio after 10yr
$210700281576.07M
Annual income
$197,637,196,959,660,220.00/yr
Blended yield
93.80%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

BRYAF
No analyst data
Altman Z
0.5
Piotroski
4/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BRYAF buys
0
PFE buys
0
No recent congressional trades found for BRYAF or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBRYAFPFE
Forward yield2976.19%6.13%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$421400563152.10M$49.6K
Annual income after 10y$395,274,393,919,294,200.00$26,258.71
Total dividends collected$419593464043.04M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BRYAF vs PFE ($10,000, DRIP)

YearBRYAF PortfolioBRYAF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$308,319$297,619.05$9,153$693.39+$299.2KBRYAF
2$8,905,754$8,575,852.46$8,593$849.25+$8.90MBRYAF
3$241,036,011$231,506,854.42$8,336$1,066.78+$241.03MBRYAF
4$6,113,777,105$5,855,868,573.20$8,437$1,384.80+$6113.77MBRYAF
5$145,356,362,959$138,814,621,456.31$9,013$1,875.40+$145356.35MBRYAF
6$3,239,968,150,316$3,084,436,841,950.57$10,306$2,680.72+$3239968.14MBRYAF
7$67,720,563,015,376$64,253,797,094,537.52$12,820$4,101.38+$67720563.00MBRYAF
8$1,327,608,714,870,041$1,255,147,712,443,588.80$17,673$6,826.70+$1327608714.85MBRYAF
9$24,416,980,591,406,588$22,996,439,266,495,650.00$27,543$12,591.86+$24416980591.38MBRYAF
10$421,400,563,152,099,260$395,274,393,919,294,200.00$49,560$26,258.71+$421400563152.05MBRYAF

BRYAF vs PFE: Complete Analysis 2026

BRYAFStock

Berjaya Corporation Berhad provides consumer marketing, direct selling, and retailing services in Malaysia and internationally. It also engages in the financial services; hotels, resorts, vacation timeshare, and recreation development and operation; property investment, development, and management; gaming and lottery management; food and beverage; and telecommunication and information technology-related services, solutions, and products businesses. In addition, the company produces, trades in, distributes, and rents motor vehicles; operates clubs; produces and supplies potable water; operates book stores and a private university college; operates and franchises restaurants and cafes; and provides digital media marketing, management, educational, training, consultancy, real estate agency and valuation, and civil engineering contracting services. Further, it promotes and operates esports; owns and operates pharmacy stores; imports, trades in, distributes, markets, and retails products sold in pharmacies, and health and beauty retailers; collects, transports, stores, treats, recovers, disposes, and manages hazardous and toxic, and medical waste; and offers securities and printing, information technology consultancy, medical laboratory, investment advisory, asset and fund management, hire purchase, loan financing, money lending, stock and share broking, nominee, environmental engineering and river cleaning, interior design, security, jet charter, aircraft leasing, spa management, casino, insurance agency, telecommunications, system integration, logistics, warehousing, and courier services. Additionally, it engages in the sanitary landfills; wearing apparel retail; household, personal and healthcare, consumer, and skin care products; organic food; electricity generation; computer hardware trading; palm oil and kernel; and travel and tour agency businesses. The company was founded in 1984 and is based in Kuala Lumpur, Malaysia.

Full BRYAF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this BRYAF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BRYAF vs SCHDBRYAF vs JEPIBRYAF vs OBRYAF vs KOBRYAF vs MAINBRYAF vs JNJBRYAF vs MRKBRYAF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.